Keywords: Contrast Agent, Molecular ImagingThis work investigated the performance of a novel class of Mn(II) T1 contrast agents made from a commercially available chelator with various lipophilic targeting moieties added to promote uptake through the human derived OATP1B1 and OATP1B3 transporters. Agent performance was assessed in vitro using cells engineered to express the human OATPs, and in vivo by assessing liver uptake in mice where other OATP isoforms are present. In vitro measurements suggested targeting of agents to human OATPs where in vivo imaging revealed strong contrast enhancement in murine livers, with no evident toxicity at a 0.1 mmol/kg dose.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords